ABVC BioPharma, Inc.
ABVC
$0.911
$0.0354.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 229.30K | -186.60K | -1.01M | -3.93M | -383.30K |
| Total Depreciation and Amortization | 179.30K | 7.00K | 13.30K | 1.30K | 359.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -681.70K | 338.70K | 475.30K | 3.17M | 70.70K |
| Change in Net Operating Assets | -220.60K | 12.60K | -490.00K | 289.60K | -477.30K |
| Cash from Operations | -493.60K | 171.70K | -1.01M | -473.20K | -430.50K |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 154.20K |
| Cash from Investing | -- | -- | -- | -- | 154.20K |
| Total Debt Issued | 689.60K | 0.00 | 0.00 | 282.10K | 110.10K |
| Total Debt Repaid | -177.00K | -179.10K | -- | -- | -186.50K |
| Issuance of Common Stock | 76.30K | 33.70K | 868.50K | -- | 0.00 |
| Repurchase of Common Stock | -7.30K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 394.10K | 114.80K |
| Cash from Financing | 581.50K | -145.40K | 868.50K | 676.20K | 38.40K |
| Foreign Exchange rate Adjustments | 6.10K | 800.00 | 229.30K | -260.80K | -166.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.90K | 27.10K | 83.80K | -57.80K | -404.20K |